Gevo price to sales ratio GEVO

Market value divided by revenue over the last twelve months, since 2012.

Today, Oct 23, 2026: 1.6×
10-year median: 1.3×
Against its 10-year history: 53rd; percentile: 0 is its lowest day, 100 its highest
10-year range: 0.1× to 147×
Peer median: 0.8×

Gevo's price to sales ratio is 1.6× as of Oct 23, 2026.

That is above its ten-year median of 1.3×, close to the middle of its last ten years.

Over that time it ranged from 0.1× in Sep 2017 to 147× in Feb 2021.

The median for 6 specialty chemicals stocks of a similar size is 0.8×.

Price to sales ratio over time

median 1.3×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	1.6×	1.6×	4.4×
2025	4.1×	3.9×	43.8×
2024	32.3×	7.1×	41.3×
2023	n/m a value too high to mean anything
2022	n/m a value too high to mean anything
2021	102×	44.3×	147×
2020	42.7×	0.3×	42.7×
2019	1.4×	0.6×	1.8×
2018	0.5×	0.1×	1.1×
2017	0.5×	0.1×	1.0×
2016	0.8×	0.2×	1.7×
2015	0.3×	0.3×	25.9×
2014	26.7×	22.6×	178×
2013	116×	28.1×	176×
2012	23.1×	20.3×	51.1×

Against its peers

Companies in Chemicals - Specialty nearest Gevo's size, closest first, today.

Company	Price to sales ratio
GEVOGevo	1.6×
ALTOAlto Ingredients	0.3×
LXFRLuxfer	1.3×
LXULSB Industries	1.1×
WLKPWestlake Chemical Partners	0.6×
GPREGreen Plains	0.5×
REXREX AMERICAN RESOURCES	2.0×
Peer median	0.8×

Where Gevo ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Gevo

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.